Unknown NA INTERVENTIONAL 2-arm NCT04744571

Safety and Efficacy of Drug-Coated Balloon Angioplasty for the Treatment of Chronic Total Occlusions

Sponsor: Beijing Anzhen Hospital

Conditions Chronic Total Occlusion of Coronary Artery Coronary Artery Disease Coronary Occlusion Drug-Eluting Stents Percutaneous Coronary Intervention

Interventions aspirin, betaloc, atorvastatin, rosuvastatin, clopidogrel, ticagrelor coronary wires. or coronary balloons drug-coated balloon drug-eluting stent

Updated 4 times since 2021 Last updated: Feb 6, 2021 Started: Feb 28, 2021 Primary completion: Dec 31, 2022 Completion: Jan 31, 2023

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT04744571, this NA trial focuses on Chronic Total Occlusion of Coronary Artery and Coronary Artery Disease and remains ongoing. Sponsored by Beijing Anzhen Hospital, it has been updated 4 times since 2021, reflecting limited change activity. This study contributes longitudinal data to the cardiovascular research landscape.

Status Flow

Change History

4 versions recorded

Sep 2024 — Present [monthly]

Unknown NA
Jul 2024 — Sep 2024 [monthly]

Unknown NA

Status: Unknown Status → Unknown
Mar 2023 — Jul 2024 [monthly]

Unknown Status NA

Status: Enrolling By Invitation → Unknown Status
Mar 2021 — Mar 2023 [monthly]

Enrolling By Invitation NA

First recorded

Feb 2021

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Beijing Anzhen Hospital

Data source: Beijing Anzhen Hospital

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Beijing, China